Warnings and Cautions BPC-157 lacks regulatory approval for human use in most countries, and its safety profile in humans remains incompletely understood due to limited clinical trials
This difference explains why semaglutide is dosed weekly while sermorelin requires daily injections
It's that the rules change significantly from state to state
BPC-157 is considered a research peptide, or research chemical, which means its not actually legal to sell BPC-157 for human use in the U.S
Peptide / Compound Information Source: PubChem for research reference only
A hallmark of the ligand interactions it that both bind FcRn in a strictly pH-dependent manner, with binding at mildly acidic pH (pH 6.55.0) and no binding or release at pH 7.4 [23, 28,29,30,31,32,33,34,35,36,37,38,39,40,41,42]